Abstract
Smoking has been associated with myocardial infarction, independently of its association with atherosclerotic lesions (1). Since coronary thrombosis is the proximate cause of acute myocardial infarction (2) as confirmed recently by the success of thrombolysis to reopen coronary arteries (3), smoking could act directly on the predisposition to thrombosis. Platelet reactivity seems to play a key role in the thrombotic tendency since, in a recent prospective study on 2500 subjects in Wales (5), aspirin significantly reduced acute coronary events (4) and platelet hyperaggregability to ADP was significantly related to the prevalent cases of myocardial infarction. Thus, it is important to determine whether smoking increases platelet reactivity and additionally which smoke components could be involved in this effect. Finally, in the Seven Country Study (6), smoking was less of a risk factor for heart attacks in Southern Europe and Japan than in the USA and northern Europe. Since the consumption of saturated fats was much lower in Japan (3% of calories) and southern Europe (7–10%) than in the USA (18%) and northern Europe (19–22%), the effect of smoking on platelets could be additive to that of saturated fats which are known to markedly increase their reactivity (7). Results of our studies on the effect of smoking, smoke components and saturated fats on platelet function tests are briefly reviewed hereafter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A.J. Hartz, P.N. Barboriak, A.J. Anderson, R.B. Hoffmann, and JJ. Barboriak. Smoking, coronary artery occlusion and nonfatal myocardial infarction, J.A.M.A. 246:851 (1981).
M.A. De Wood, J. Spores, R. Notske. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction, N. Engl. J. Med. 303:897 (1980).
AIMS TRIAL study group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial, Lancet, 1:545 (1988).
V. Fuster, M. Cohen, J. Halpern. Aspirin in the prevention of coronary disease, N. Engl. J. Med. 321:183 (1989).
P.C. Elwood, S. Renaud, D.S. Sharp, A.O. Beswick, J.R. O’Brien and J.W.G. Yarnell. Ischaemic heart disease and platelet aggregation: the Caerphilly collaborative heart disease study (Submitted for publication).
A. Keys, Seven Countries. A multivariate analysis of death and coronary heart disease. Harvard University Press, Cambridge, MA, USA (1980).
S. Renaud, R. Morazain, F. Godsey, E. Dumont, C. Thevenon, J.L. Martin, F. Mendy. Nutrients, platelet function and composition in nine groups of French and British farmers, Atherosclerosis 60:37 (1986).
P.H. Levine. An acute effect of cigarette smoking on platelet function, Circulation 48:619 (1973).
W. Siess, R. Lorenz, P. Roth, P.C. Weber, Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion, Circulation 66:44 (1983).
S. Renaud, D. Blache, E. Dumont, C. Thevenon, and T. Wissendanger. Platelet function after cigarette smoking in relation to nicotine and carbon monoxide. Clin. Pharmacol. Ther. 36:389 (1984).
S. Renaud, E. Dumont, F. Baudier, E. Ortchanian, and I.S. Symington. Effect of smoking and dietary saturated fats on platelet functions in Scottish farmers, Cardiovasc. Res. 19:155 (1985).
S. Renaud, and F. Lecompte. Hypercoagulability induced by hyperlipemia in rat, rabbit and man. Role of platelet factor 3, Circ. Res. 27:1003 (1979).
M.A.H. Russell, M. Jarvis, R. Iyer, and C. Feyerabend. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers, Br. Med. J. 1:972 (1980).
D. Blache, C. Thevenon, M. Ciavatti, and S. Renaud. A sensitive method for the routine determination of plasma nicotine by flame ionization gas-liquid chromatography, Analyt. Biochem. 143:316 (1984).
M.E. McNabb, R.V. Ebert, and K. McCusker. Plasma nicotine levels produced by chewing nicotine gum, J.A.M.A. 248:865 (1982).
K. Brinson. Effect of nicotine on human blood platelet aggregation. Atherosclerosis 20:127 (1975).
S.R. Saba, and R.G. Mason. Some effects of nicotine on platelets, Thromb. Res.
S. Renaud, R. Morazain, F. Godsey, E. Dumont, I.S. Symington, E.M. Gillanders, and J.R. O’Brien. Platelet functions in relation to diet and serum lipids in British farmers, Brit. Heart J. 46:562 (1981).
R. Doll, R. Peto. Mortality in relation to smoking: 20 years’ observations on male British doctors, Brit. Med. J. 2:1526 (1976).
T. Gordon, N.B. Kannel, D. McGee, and T.R. Dawber. Death and coronary attacks in men after giving up cigarette smoking, Lancet 2: 1345 (1974).
W.C. Willett, C.H. Hennekens, C. Bain, B. Rosner and F.E. Speizer. Cigarette smoking and non-fatal myocardial infarction in women, Amer. J. Epidemiol. 113:575 (1981).
J.T. Doyle, T.R. Dawber, W.B. Kannel, S.H. Kinch, and H.A. Kahn. The relationship of cigarette smoking to coronary heart disease, J.A.M.A. 190:886 (1964).
G. Grignani, G. Gamba and E. Ascari. Cigarette-smoking effect on platelet function, Thromb. Haemost. 37:442 (1977).
I. Hjermann, K. Velve Byre, I. Holme, and P. Leren. Effect of diet and smoking intervention on the incidence of coronary heart disease, Lancet 2:1303 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Renaud, S. (1990). Cigarette Smoking and Platelet Function: Relation to Nicotine, Carbon Monoxide and Saturated Fat. In: Diana, J.N. (eds) Tobacco Smoking and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 273. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5829-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5829-9_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5831-2
Online ISBN: 978-1-4684-5829-9
eBook Packages: Springer Book Archive